Pinned straw:
@edgescape, thanks for your table showing the HY-on HY comparison. It helped explain what seemed to be to a strange market reaction to another sterling set of XRF results.
The numbers do indeed show 2HFY23 revenue growth of 4% vs 1HFY23. But 1HFY23's revenue growth of 26% vs 2HFY22 seems abnormal vs the "normal" revenue growth of prior half's of between 9% to 16%.
The proportion of revenue growth across both half's (just applying simple math, proportion of each half's growth/total % growth across the half's):
FY21: 57% 1H vs 43% 2H
FY22: 45% 1H vs 55% 2H
FY23: 86% 1H vs 14% 2H
Rather than this being a 2HFY23 growth stalled situation, it looks more like a timing difference issue where the growth occured mostly in 1HFY23 instead of being spread across both half's as in FY21 and FY22. Not only that, XRF then grew that already significant revenue jump from 1HFY23 by a further 4% in 2HFY23, to arrive at FY23's results where revenue was up 38% YoY.
Not sure if my logic above is correct, but it feels irrational that the market penalises XRF for 38% YoY revenue growth because of this timing difference ...
Discl: I topped up IRL this week ...